Randstad (RAND) Q4 2024 earnings summary

Executive summary

• FY 2024 revenue declined 7% year-over-year to EUR 24.1 billion, with Q4 revenue down 5.5% to EUR 6.1 billion, reflecting ongoing labor market challenges and subdued demand in key regions.

• Q4 EBITDA/EBITA was EUR 200 million (3.3% margin), with full-year EBITDA/EBITA at EUR 754 million (3.1% margin); net income for Q4 was EUR (149) million, impacted by impairments and one-off items.

• Strategic cost actions, restructuring, and digital investments were implemented to position for future growth.

• A dividend of EUR 1.62 per share (EUR 285 million total) is proposed, in line with capital allocation policy.

• Significant impairments and fair value adjustments, including EUR 260 million on goodwill and loans, impacted net income.

Financial highlights

• Q4 organic revenue declined 5.5% year-over-year; full-year revenue was EUR 24.1 billion, down 7%.

• Q4 EBITDA/EBITA was EUR 200 million (3.3% margin); full-year EBITDA/EBITA was EUR 754 million (3.1% margin).

• Q4 gross margin was 18.8%, down from 20.7% year-over-year, mainly due to business mix and idle time.

• Free cash flow for Q4 was EUR 87 million; full-year leverage ended at 1.6x; net debt at year-end was EUR 1,280 million.

• Return on invested capital fell to 8.9% (FY 2023: 14.6%).

Outlook and guidance

• Q1 2025 organic revenue growth expected to align with Q4 2024 trends, with further market stabilization anticipated.

• Q1 2025 gross margin expected to be modestly higher sequentially; operating expenses to be modestly lower.

• Full consolidation of Zorgwerk in Q1 2025 will add approximately EUR 25 million revenue per quarter.

• Effective tax rate guidance for 2025 is 26%-28%.